Case Study: a large pharmaceutical company improves ESG performance with Wolters Kluwer ELM Solutions' Enablon platform

How a Large Pharmaceutical Firm Improved ESG Through a Single Platform

A large pharmaceutical company was looking to improve its environmental, health, and safety strategy by moving from a basic policy-driven approach to a more standardized, global model with better visibility into EHS and sustainability performance. Wolters Kluwer ELM Solutions is named in the case study as the vendor, and the company used the Enablon platform to support its phased digital transformation.

Wolters Kluwer ELM Solutions implemented Enablon in a module-by-module rollout, with the company also moving enterprise risk management onto the platform. The result was stronger EHS&S performance, which helped the company set new goals and KPIs and achieve four of five environmental goals ahead of schedule, along with significant reductions in TRIR, LTIR, and greenhouse gas emissions.